Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01643-X/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_esccardio24&_hsenc=p2ANqtz-9XjHDdXEvJRUtKdaa-hEhN4jGTKMeaa3j5rsilE_lX0Vy9yGyFvdm9Wf3rc0Dqh9wcgEllgVQUVaSiJQ9Y1-zg6FFddg&_hsmi=323667268&utm_content=322855643&utm_source=hs_email